Menéndez Rodríguez Martín, García-Morales Natalia, Seoane Pillado Teresa, Garau Ramírez Jorge, Traver Salvador Alba, Hervás Jiménez Yésica, Pin Vieito Noel, Menéndez Rodríguez Luis, Cubiella Joaquín
Primary Health Center Salceda de Caselas, Gerencia de Gestión Integrada de Vigo, SERGAS, Vigo, Spain; Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Digestive Service, Complexo Hospitalario Universitario de Vigo Sergas, Vigo, Spain; South Galicia Health Research Institute, Vigo, Spain.
Gastroenterol Hepatol. 2023 Mar;46(3):185-194. doi: 10.1016/j.gastrohep.2022.05.003. Epub 2022 May 20.
Colorectal cancer is the second cancer-related cause of death in the world. Tumour stage at diagnosis is the principal prognosis factor of survival. However, the participation in the programme is around 50%. The aim of the study was to identify the benefits and barriers perceived by the population when participating in a colorectal cancer screening programme with faecal occult blood test.
We carried out a cases-controls study with 408 participants. We analyzed epidemiological and social variables associated with lifestyle and behavioural factors based in the Health Belief Model. We conducted a descriptive analysis, and identified variables associated to adherence by a logistic regression.
Variables independently associated with the participation in a colorectal cancer screening programme were age (OR 1.06; 95% CI: 1.01-1.11), having a stable partner (OR 1.96; 95% CI: 1.20-3.18), the level of education (OR 1.59; 95% CI: 1.02-2.47) and two of the barriers to participate in the faecal occult blood test screening: "you don't know how to do one" (OR=0.46; 95% CI: 0.23-0.93) and "it is not that important right now" (OR=0.43; 95% CI: 0.24-0.78).
The existing barriers for screening with faecal occult blood test are the best factor predicting. This is relevant when designing the intervention programmes, as they should focus on reducing perceived barriers to increase the participation in colorectal cancer screening, thereby reducing colorectal cancer mortality.
结直肠癌是全球第二大致癌死亡原因。诊断时的肿瘤分期是生存的主要预后因素。然而,参与该项目的比例约为50%。本研究的目的是确定人群在参与粪便潜血试验的结直肠癌筛查项目时所感知到的益处和障碍。
我们对408名参与者进行了病例对照研究。我们基于健康信念模型分析了与生活方式和行为因素相关的流行病学和社会变量。我们进行了描述性分析,并通过逻辑回归确定了与依从性相关的变量。
与参与结直肠癌筛查项目独立相关的变量有年龄(比值比1.06;95%置信区间:1.01 - 1.11)、有稳定伴侣(比值比1.96;95%置信区间:1.20 - 3.18)、教育水平(比值比1.59;95%置信区间:1.02 - 2.47)以及参与粪便潜血试验筛查的两个障碍:“不知道如何操作”(比值比 = 0.46;95%置信区间:0.23 - 0.93)和“目前没那么重要”(比值比 = 0.43;95%置信区间:0.24 - 0.78)。
粪便潜血试验筛查存在的障碍是最佳预测因素。在设计干预项目时这一点很重要,因为项目应专注于减少感知到的障碍,以提高结直肠癌筛查的参与率,从而降低结直肠癌死亡率。